Gsα deficiency in macrophages promotes tumor progression via the MAPK signaling pathway
Journal of Molecular Medicine · 2026-12 · 104 (1)
DOI: 10.1007/s00109-026-02660-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Medicine, online erschienen am 19.03.2026. Verfasst von Wenjiang Yan und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Experimental Teratology of Ministry of Education and Department of Immunology, School of Basic Medical Sciences, Qilu Hospital, Ch…. Hauptthemen laut MEDLINE: MAP Kinase Signaling System, Macrophages, Tumor-Associated Macrophages. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Scholar Project of Shandong Province of China.
Abstract (Originalsprache)
Under diverse stimuli in the tumor microenvironment, tumor-associated macrophages (TAMs) are susceptible to polarize toward an immunosuppressive phenotype. Reprogramming TAMs is a promising strategy for cancer immunotherapy. As a downstream molecule of G protein-coupled receptors, the alpha subunit of the stimulatory G protein (Gsα) plays an indispensable role in the transduction of extracellular signals to intracellular signals. However, whether Gsα is responsible for the reprogramming and polarization of TAMs is largely unknown. Here, we demonstrate that Gsα deficiency in TAMs accelerates tumor growth and metastasis in B16 and MC38 tumor cells. Further investigations revealed that Gsα upregulates the expression of CD86, CCR5, Il1b and Nos2 and inhibits CD206 and Il10 expression, which facilitates the recruitment and antitumoral activity of TAMs and contributes to the increased effector activity of CD8+ T cells. Mechanistically, Gsα promotes the proinflammatory M1-like polarization of TAMs by increasing the phosphorylation of ERK, p38 and JNK in the MAPK signaling pathway. In summary, our study indicates that Gsα-deficient TAMs exhibit protumoral activity via the MAPK pathway, suggesting a novel potential target for cancer immunotherapy based on TAMs reprogramming. KEY MESSAGES: Deficiency of Gsα in TAMs accelerates tumor growth and metastasis in B16 and MC38 tumor models in vivo and in vitro. Further investigations reveal that Gsα upregulates expression of CD86, CCR5, Il1b and Nos2, and inhibits CD206 and Il10 expression, which facilitates antitumoral activity of TAMs. Mechanistically, Gsα promotes M1 polarization of TAMs via upregulating phosphorylation of ERK, p38 and JNK in MAPK signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Experimental Teratology of Ministry of Education and Department of Immunology, School of Basic Medical Sciences, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
- National Key Laboratory for Innovation and Transformation of Luobing Theory, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and C…
- Department of Emergency, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Metabolic Diseases Branch, National Institute of Diabetes, National Institutes of Health, Digestive, and Kidney Diseases, Bethesda, MD, 20814, USA.
- Department of Pharmacology, School of Medicine, University of Nevada, Reno, NV, 89557, USA. louis700@163.com.
- Key Laboratory for Experimental Teratology of Ministry of Education and Department of Immunology, School of Basic Medical Sciences, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Taishan Scholar Project of Shandong Province of China
Zitieren
APA
Yan, W., Yang, J., Tan, S., Wang, T., Xiao, R., Li, N., Chen, M., Weinstein, L. S., He, L., Ma, C., Zhang, J., Gao, L., Liang, X., Song, X., Zhang, W., & Ma, C. (2026). Gsα deficiency in macrophages promotes tumor progression via the MAPK signaling pathway. Journal of Molecular Medicine, 104(1). https://doi.org/10.1007/s00109-026-02660-2
Vancouver
Yan W, Yang J, Tan S, Wang T, Xiao R, Li N, et al. Gsα deficiency in macrophages promotes tumor progression via the MAPK signaling pathway. Journal of Molecular Medicine. 2026;104(1). doi:10.1007/s00109-026-02660-2
BibTeX
@article{Yan2026,
author = {Yan, Wenjiang and Yang, Jingjing and Tan, Siyu and Wang, Tixiao and Xiao, Rong and Li, Na and Chen, Min and Weinstein, Lee S and He, Lifan and Ma, Chang and Zhang, Jingsu and Gao, Lifen and Liang, Xiaohong and Song, Xiaojia and Zhang, Wencheng and Ma, Chunhong},
title = {Gsα deficiency in macrophages promotes tumor progression via the MAPK signaling pathway},
journal = {Journal of Molecular Medicine},
year = {2026},
volume = {104},
number = {1},
doi = {10.1007/s00109-026-02660-2}
}
EUVIMED